Plain-English translation of NCT07731555 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Glioblastoma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study aims to understand how glioblastoma (a serious brain tumor) damages the blood-brain barrier—a protective lining that normally keeps harmful substances out of the brain. By collecting brain imaging scans, blood samples, and cognitive assessments from newly diagnosed patients at different time points, researchers hope to learn how this damage affects tumor growth, brain function, and treatment success. The goal is to improve how doctors diagnose and treat this disease in the future.
The blood-brain barrier normally protects the brain, but glioblastoma disrupts it in ways we don't fully understand. This disruption may affect how the tumor grows, how well treatments work, and how the disease impacts a patient's thinking and memory. By studying these changes across multiple time points, researchers can develop better ways to diagnose the tumor and improve treatment outcomes.
You likely qualify if…
You likely don't qualify if…
You would participate in study visits before surgery, right after surgery, at 72 hours post-surgery, at 4 weeks, and again after you complete radiation therapy. At each visit, you'll have advanced brain imaging (MRI scans), provide blood samples for testing, complete cognitive and memory assessments, and share clinical information. The tumor tissue removed during your routine surgery will also be analyzed for research purposes. This structured follow-up helps researchers track how your brain barrier changes over time and how it relates to your recovery and outcomes.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Ireland